Carr Douglas
Transaction: 08/03/2026
SELL
Change
-275
Price
$1.98
Filing
08/05/2026
Type
SELL
Century Therapeutics, Inc.
IPSC • Biotechnology
$1.67
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$344.64M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 141.1%Manageable debt level · 0.27Healthy liquidity · 5.97Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:21 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.67
Change0.00%
Shares Out205.78M
Market Cap$344.64M
Enterprise Value$259.55M
52W Range0.43 - 3.04
Beta1.60
P/E-3.14
P/B1.48
P/FCF-3.95
EV/EBITDA-2.54
EV/FCF-2.97
Price$1.67
Change0.00%
Shares Out205.78M
Market Cap$344.64M
Enterprise Value$259.55M
52W Range0.43 - 3.04
Beta1.60
P/E-3.14
P/B1.48
P/FCF-3.95
EV/EBITDA-2.54
EV/FCF-2.97
Earnings Yield-31.86%
FCF Yield-25.32%
Dividend Yield0.00%
Gross Margin88.00%
Oper. Margin-13.78%
Profit Margin-8.78%
Debt/Eq0.27
Current Ratio5.97
Quick Ratio5.97
Target$7.50
Target Upside347.81%
Target Median$4.50
Target Range2.00 - 19.00
Volume542.91K
Avg Volume1.18M
EPS Surprise0.04
Investment DNA
How strong this company looks for long-term investors
57
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Positive revenue growth · 141.1%Manageable debt level · 0.27Healthy liquidity · 5.97Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-10-20
89/100
Bullish
Bullish
7
Hold
2
Bearish
0
Price Target
2026-08-14
Low
$2.00
Mean
$2.00
Median
$2.00
High
$2.00
Insider Transactions
Recent executive and insider activity
Carr Douglas
Transaction: 06/12/2026
SELL
Change
-1,654
Price
$2.23
Filing
06/15/2026
Type
SELL
Russotti Gregory
Transaction: 06/12/2026
SELL
Change
-2,584
Price
$2.23
Filing
06/15/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Carr Douglas | SELL | -275 | $1.98 | 08/03/2026 | 08/05/2026 |
| Carr Douglas | SELL | -1,654 | $2.23 | 06/12/2026 | 06/15/2026 |
| Russotti Gregory | SELL | -2,584 | $2.23 | 06/12/2026 | 06/15/2026 |
| Cowan Chad | SELL | -358 | $2.24 | 06/11/2026 | 06/15/2026 |
| Pfeiffenberger Brent | SELL | -13,849 | $2.24 | 06/11/2026 | 06/15/2026 |
| Blackwell Kimberly | BUY | +74,000 | $2.24 | 06/11/2026 | 06/12/2026 |
| Lee Han Myung | BUY | +74,000 | $2.24 | 06/11/2026 | 06/12/2026 |
| Murphy Martin Patrick | BUY | +74,000 | $2.24 | 06/11/2026 | 06/12/2026 |
| Quimi Daphne | BUY | +74,000 | $2.24 | 06/11/2026 | 06/12/2026 |
| Riva Alessandro | BUY | +74,000 | $2.24 | 06/11/2026 | 06/12/2026 |
| Carr Douglas | SELL | -249 | $2.11 | 06/08/2026 | 06/09/2026 |
| Russotti Gregory | SELL | -524 | $2.11 | 06/08/2026 | 06/09/2026 |
| Pfeiffenberger Brent | SELL | -463 | $2.13 | 06/05/2026 | 06/09/2026 |
| Pfeiffenberger Brent | SELL | -31,172 | $2.34 | 05/15/2026 | 05/19/2026 |
| Carr Douglas | SELL | -264 | $2.34 | 05/04/2026 | 05/06/2026 |
| Murphy Martin Patrick | OTHER | 0 | Not reported | 12/09/2025 | 04/10/2026 |
| Murphy Martin Patrick | BUY | +88,000 | $0.59 | 12/09/2025 | 04/10/2026 |
| Cowan Chad | SELL | -1,365 | $2.19 | 04/01/2026 | 04/03/2026 |
| Russotti Gregory | SELL | -10,076 | $2.55 | 03/12/2026 | 03/16/2026 |
| Carr Douglas | SELL | -7,043 | $2.55 | 03/12/2026 | 03/16/2026 |